NYSE$AHR

American Healthcare REIT Inc · Q4 2025 earnings

Q4 2025 earnings · · After market close · Investor relations

Briefing

American Healthcare REIT reported Q4 2025, revenue of $450M, net income of $10.8M.

For Q4 2025, American Healthcare REIT reported revenue of $450M, net income of $10.8M. Management discusses segment performance, capital allocation, and macro risks in the quarterly filing.

  • Revenue $450M.
  • Net income $10.8M.
  • American Healthcare REIT MD&A covers liquidity, credit, and operating priorities.

Headline financials

Total Revenue

$450M

Previous: $543M-17.1%
EPS (adj)

$0.46

Previous: $0.40+15.0%
SHOP SS NOI Growth

24.6%

No prior period
Total Portfolio SS NOI Growth

11.8%

No prior period
ISHC SS NOI Growth

14.0%

No prior period
Outpatient Medical SS NOI Growth

2.2%

No prior period
Triple-Net SS NOI Growth

1.8%

No prior period
Net Debt to Annualized Adj EBITDA

3.4

No prior period
Net Income

$10.8M

Previous: -$31.8M+134.0%
Operating Income

$36.4M

Previous: $24.5M+48.6%

Revenue & EPS history

American Healthcare REIT Inc · Revenue · Quarterly

$450M

Q4 2025-17.1%vs Q4 2024
Beat estimate in 3 of 8 quarters(38%)
ActualEstimate

Revenue by segment

American Healthcare REIT Inc · $543M total across 4 segments · Q4 2024

  • ISHC
    $423M—
  • SHOP
    $73.5M—
  • Outpatient Medical
    $33.3M—
  • Triple-Net Leased
    $12.6M—

Forward guidance

The quarterly filing discusses operating priorities, capital returns, and sector risks; numeric multi-quarter bridges vary by issuer.

Tailwinds

  • MD&A highlights liquidity, capital, and core business trends.
  • Segment or product commentary supports the earnings narrative.

Headwinds

  • Macro, rates, or input costs may pressure near-term margins.
  • One-time items can affect year-over-year comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 11 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

+1.8%

Avg return

Earnings day

+2.2%

Avg return

5 days after

+3.9%

Avg return

30 days after

64%

7 / 11 earnings

Positive

+8.3%

Q1 2025

Best reaction

-2.1%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026———
Q1 2026+4.3%+4.1%-4.2%
Q4 2025-2.1%-2.5%-11.4%
Q3 2025+3.0%-0.1%+4.6%
Q2 2025+1.3%+2.0%+7.2%
Q1 2025+8.3%+6.1%+10.2%
Q4 2024-1.3%+0.7%+0.8%
Q3 2024+1.2%+2.7%+7.1%
Q2 2024+3.3%+3.6%+35.1%
Q1 2024-0.1%+3.5%+6.2%
Q2 2023+2.8%+1.3%-6.8%
Q4 2023-0.8%+3.2%-5.9%
Q3 2023———
Q1 2023———
Q4 2022———
Q3 2022———
Q2 2022———
Q1 2022———
Q4 2021———
Q3 2021———
Q2 2021———
Q1 2021———
Q4 2020———
Q3 2020———
Q2 2020———
Q1 2020———
Q4 2019———
Q3 2019———
Q2 2019———
Q1 2019———
Q3 2018———
Q2 2018———
Q1 2018———
Q3 2017———
Q2 2017———
Q1 2017———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro